Atossa Genetics (ATOS) Competitors $0.89 -0.02 (-2.54%) Closing price 04:00 PM EasternExtended Trading$0.90 +0.01 (+1.50%) As of 05:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ATOS vs. PRTC, MBX, RZLT, RGNX, TRML, SVRA, ERAS, TECX, ETON, and ITOSShould you be buying Atossa Genetics stock or one of its competitors? The main competitors of Atossa Genetics include PureTech Health (PRTC), MBX Biosciences (MBX), Rezolute (RZLT), REGENXBIO (RGNX), Tourmaline Bio (TRML), Savara (SVRA), Erasca (ERAS), Tectonic Therapeutic (TECX), Eton Pharmaceuticals (ETON), and iTeos Therapeutics (ITOS). These companies are all part of the "pharmaceutical products" industry. Atossa Genetics vs. Its Competitors PureTech Health MBX Biosciences Rezolute REGENXBIO Tourmaline Bio Savara Erasca Tectonic Therapeutic Eton Pharmaceuticals iTeos Therapeutics Atossa Genetics (NASDAQ:ATOS) and PureTech Health (NASDAQ:PRTC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership. Which has more volatility and risk, ATOS or PRTC? Atossa Genetics has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Comparatively, PureTech Health has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500. Which has stronger earnings & valuation, ATOS or PRTC? PureTech Health has higher revenue and earnings than Atossa Genetics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAtossa GeneticsN/AN/A-$25.50M-$0.21-4.25PureTech Health$4.83M92.42$27.78MN/AN/A Do institutionals & insiders hold more shares of ATOS or PRTC? 12.7% of Atossa Genetics shares are held by institutional investors. Comparatively, 0.0% of PureTech Health shares are held by institutional investors. 8.7% of Atossa Genetics shares are held by company insiders. Comparatively, 5.3% of PureTech Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media refer more to ATOS or PRTC? In the previous week, PureTech Health had 3 more articles in the media than Atossa Genetics. MarketBeat recorded 4 mentions for PureTech Health and 1 mentions for Atossa Genetics. Atossa Genetics' average media sentiment score of 1.89 beat PureTech Health's score of 0.47 indicating that Atossa Genetics is being referred to more favorably in the media. Company Overall Sentiment Atossa Genetics Very Positive PureTech Health Neutral Is ATOS or PRTC more profitable? PureTech Health's return on equity of 0.00% beat Atossa Genetics' return on equity.Company Net Margins Return on Equity Return on Assets Atossa GeneticsN/A -33.90% -31.53% PureTech Health N/A N/A N/A Do analysts recommend ATOS or PRTC? Atossa Genetics presently has a consensus price target of $6.17, indicating a potential upside of 591.64%. PureTech Health has a consensus price target of $45.00, indicating a potential upside of 142.13%. Given Atossa Genetics' higher possible upside, research analysts clearly believe Atossa Genetics is more favorable than PureTech Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Atossa Genetics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33PureTech Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 SummaryPureTech Health beats Atossa Genetics on 7 of the 12 factors compared between the two stocks. Get Atossa Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATOS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ATOS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATOS vs. The Competition Export to ExcelMetricAtossa GeneticsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$115.17M$6.67B$5.57B$9.31BDividend YieldN/A1.20%4.23%4.03%P/E Ratio-4.2525.4928.6119.73Price / SalesN/A87.22411.30174.40Price / CashN/A20.3636.0257.96Price / Book1.564.668.235.67Net Income-$25.50M$174.76M$3.23B$257.79M7 Day Performance-0.93%-1.12%0.01%0.54%1 Month Performance4.76%1.23%5.63%8.86%1 Year Performance-36.31%2.59%26.55%14.22% Atossa Genetics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATOSAtossa Genetics3.1424 of 5 stars$0.89-2.5%$6.17+591.6%-34.7%$115.17MN/A-4.258Positive NewsPRTCPureTech Health2.4865 of 5 stars$18.01flat$45.00+149.9%-22.1%$432.60M$4.83M0.00100News CoverageMBXMBX Biosciences1.7086 of 5 stars$12.88+3.3%$37.50+191.1%N/A$430.50MN/A0.0036Analyst ForecastGap UpRZLTRezolute2.3926 of 5 stars$4.98+3.3%$11.83+137.6%+5.4%$425.89MN/A-4.3340High Trading VolumeRGNXREGENXBIO3.9897 of 5 stars$8.43-3.5%$31.63+275.1%-36.0%$422.85M$83.33M-2.71370TRMLTourmaline Bio2.0368 of 5 stars$15.96-2.8%$49.33+209.1%+22.0%$409.85MN/A-4.9744News CoverageSVRASavara2.1602 of 5 stars$2.34+6.8%$5.60+139.3%-53.7%$404.45MN/A-4.8720Positive NewsHigh Trading VolumeERASErasca3.0858 of 5 stars$1.42-1.4%$4.57+221.9%-54.2%$402.27MN/A-2.29120TECXTectonic Therapeutic2.4872 of 5 stars$20.78-2.6%$83.60+302.3%+28.8%$388.03MN/A-2.84120Positive NewsETONEton Pharmaceuticals2.101 of 5 stars$14.39-0.4%$29.67+106.2%+332.0%$385.94M$39.01M-79.9420ITOSiTeos Therapeutics3.301 of 5 stars$10.07-1.1%$15.86+57.5%-37.9%$385.38M$35M-3.3190 Related Companies and Tools Related Companies PRTC Alternatives MBX Alternatives RZLT Alternatives RGNX Alternatives TRML Alternatives SVRA Alternatives ERAS Alternatives TECX Alternatives ETON Alternatives ITOS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ATOS) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atossa Genetics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atossa Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
